EDESA BIOTECH, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
EDESA BIOTECH, INC. (EDSA) had Lessee, Operating Lease, Liability, to be Paid, Year One of $20.02 thousand as of 2024-09-30, per its 10-K filed 2024-12-13.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2024-12-13
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $20.02K.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $19.78K.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $39.96K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $61.23K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2024-09-30 | $20.02K 10-K · filed 2024-12-13 |
| 2024-06-30 | $19.78K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $39.96K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $61.23K 10-Q · filed 2024-02-09 |
| 2023-09-30 | $79.70K 10-K · filed 2023-12-15 |
| 2023-06-30 | $81.69K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $79.99K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |